Logo Logo Logo Logo Logo
  • COMPANY
    • ABOUT US
    • Management team
    • Board of Directors
    • Scientific Advisory Board
    • Main Investors
    • Business Development
    • CONTACT US
  • SCIENCE
    • SNP-Technology
    • Intellectual Property
  • PIPELINE
    • Overview
    • OCS-01 Diabetic macular edema
    • OCS-01 Post Cataract Surgery Inflammation
    • OCS-02 Uveitis
    • OCS-02 Dry Eye
  • NEWS
    • Press releases
  • CAREERS
  • COMPANY

    • ABOUT US
    • Management team
    • Board of Directors
    • Scientific Advisory Board
    • Main Investors
    • Business Development
    • CONTACT US
  • SCIENCE

    • SNP-Technology
    • Intellectual Property
  • PIPELINE

    • Overview
    • OCS-01 Diabetic macular edema
    • OCS-01 Post Cataract Surgery Inflammation
    • OCS-02 Uveitis
    • OCS-02 Dry Eye
  • NEWS

    • Press releases
  • CAREERS

Press Releases 2018

November 20, 2018

 

Oculis Strengthens its Global Clinical and Business Development Capabilities

September 25, 2018

 

Oculis appoints Pravin U. Dugel, M.D. as Chairman of its Scientific Advisory Board

September 27, 2018

 

Prof. Stefansson awarded Peter Watson prize and chair of Cambridge Ophtha. symposium

September 19, 2018

 

Oculis elects Anthony Rosenberg David A. Weber to its Board of Directors

Press Releases 2020/2021
Press Releases 2019
Contact us

Oculis Switzerland
Corporate Headquarters
EPFL Innovation Park Building D
Route J-D. Colladon
1015 Lausanne
Switzerland

+41 21 711 3970

 

Oculis Iceland
Alfheimar 74
6th Floor
104 Reykjavik
Iceland

+354 546 4440

Copyright © 2020 Oculis SA.

    © Oculis – Private policy

    © L’autreagence 2019